These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 31626097

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Clinical significance of soluble hemoglobin scavenger receptor CD163 (sCD163) in sepsis, a prospective study.
    Feng L, Zhou X, Su LX, Feng D, Jia YH, Xie LX.
    PLoS One; 2012; 7(7):e38400. PubMed ID: 22911680
    [Abstract] [Full Text] [Related]

  • 24. CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients.
    Yang L, Wang F, Wang L, Huang L, Wang J, Zhang B, Zhang Y.
    Oncotarget; 2015 Apr 30; 6(12):10592-603. PubMed ID: 25871392
    [Abstract] [Full Text] [Related]

  • 25. Pleural IFN-γ release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion.
    Tang Y, Zhang J, Huang H, He X, Zhang J, Ou M, Li G, Zeng C, Ye T, Ren L, Liu Y, Zhang G.
    BMC Infect Dis; 2019 Jan 16; 19(1):55. PubMed ID: 30651075
    [Abstract] [Full Text] [Related]

  • 26. Utility of Macrophage-activated Marker CD163 for Diagnosis and Prognosis in Pulmonary Tuberculosis.
    Suzuki Y, Shirai M, Asada K, Miwa S, Karayama M, Nakamura Y, Inui N, Shirai T, Hayakawa H, Baba S, Suda T.
    Ann Am Thorac Soc; 2017 Jan 16; 14(1):57-64. PubMed ID: 27684274
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Combined detections of interleukin 27, interferon-γ, and adenosine deaminase in pleural effusion for diagnosis of tuberculous pleurisy.
    Wu YB, Ye ZJ, Qin SM, Wu C, Chen YQ, Shi HZ.
    Chin Med J (Engl); 2013 Jan 16; 126(17):3215-21. PubMed ID: 24033939
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Predictive Factors and Treatment Outcomes of Tuberculous Pleural Effusion in Patients With Cancer and Pleural Effusion.
    Lee J, Lee YD, Lim JK, Lee DH, Yoo SS, Lee SY, Cha SI, Park JY, Kim CH.
    Am J Med Sci; 2017 Aug 16; 354(2):125-130. PubMed ID: 28864369
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Differential diagnosis between lymphoma-associated malignant pleural effusion and tuberculous pleural effusion.
    Kim CH, Oh HG, Lee SY, Lim JK, Lee YH, Seo H, Yoo SS, Lee SY, Cha SI, Park JY, Lee J.
    Ann Transl Med; 2019 Aug 16; 7(16):373. PubMed ID: 31555687
    [Abstract] [Full Text] [Related]

  • 37. Diagnostic value of interleukin 21 and carcinoembryonic antigen levels in malignant pleural effusions.
    Bunjhoo H, Wang ZY, Chen HL, Cheng S, Xiong WN, Xu YJ, Cao Y.
    Asian Pac J Cancer Prev; 2012 Aug 16; 13(7):3495-9. PubMed ID: 22994784
    [Abstract] [Full Text] [Related]

  • 38. Role of cancer ratio and other new parameters in the differential diagnosis of malignant pleural effusion.
    Ren Z, Xu L.
    Clinics (Sao Paulo); 2021 Aug 16; 76():e2515. PubMed ID: 33909825
    [Abstract] [Full Text] [Related]

  • 39. Determination of Interleukin 27-Producing CD4(+) and CD8(+) T Cells for The Differentiation Between Tuberculous and Malignant Pleural Effusions.
    Liu YL, Wu YB, Zhai K, Wang XJ, Shi HZ.
    Sci Rep; 2016 Jan 19; 6():19424. PubMed ID: 26783266
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.